Demographic characteristics of participants
| Home PR n=80 | Centre-based PR n=86 | |
|---|---|---|
| Age, years | 69 (13) | 69 (10) |
| Male/female, n | 48/32 | 51/35 |
| Pack years | 47 (36) | 50 (29) |
| Current smoker, n (%) | 10 (13) | 18 (21) |
| FEV1, L | 1.31 (0.48) | 1.25 (0.60) |
| FEV1 per cent predicted | 52 (19) | 49 (19) |
| FVC, L | 2.71 (0.68) | 2.71 (0.89) |
| FVC per cent predicted | 78 (17) | 79 (22) |
| FEV1/FVC | 0.47 (0.16) | 0.45 (0.14) |
| BMI, kg/m2 | 29 (7) | 28 (6) |
| 6 min walk distance, m | 395 (121) | 411 (107) |
| LTOT, n (%) | 2 (3) | 6 (7) |
| MMRC, n (%) | ||
| 0 | 2 (3) | 0 (0) |
| 1 | 33 (41) | 36 (42) |
| 2 | 22 (27) | 28 (33) |
| 3 | 21 (26) | 19 (22) |
| 4 | 2 (3) | 3 (3) |
| HADS anxiety, n (%) n=164 | ||
| No case | 47 (59) | 56 (67) |
| Borderline | 16 (20) | 14 (17) |
| Case | 17 (21) | 14 (17) |
| HADS depression, n (%) n=164 | ||
| No case | 59 (75) | 62 (74) |
| Borderline | 16 (20) | 14 (17) |
| Case | 4 (5) | 8 (9) |
| PRAISE | 48 (7) | 46 (9) |
| Number of comorbidities (median, IQR) | 4 (2–6) | 5 (3–6) |
| COTE | 1.58 (2.52) | 2.00 (3.10) |
| COTE≥4 | 15 (19) | 19 (22) |
| n=29 | n=38 | |
| Steps/day | 3836 (2657) | 3670 (2532) |
| Sedentary awake time, min | 669 (124) | 718 (155) |
| MVPA, min/day | 68 (29–121) | 79 (24–136) |
| Bouts of MVPA lasting ≥10 min | 0.67 (0.06–2.58) | 0.75 (0.13–2.63) |
| Duration of MVPA in bouts, min/day | 11 (1–34) | 12 (1–42) |
Data are mean (SD) except where otherwise indicated. Data for number of comorbidities and MVPA are median (IQR).
BMI, body mass index; COTE, COPD-specific comorbidity test; HADS, Hospital Anxiety and Depression Scale; LTOT, long-term oxygen therapy; MMRC, modified Medical Research Council dyspnoea scale; MVPA, moderate and vigorous physical activity; PR, pulmonary rehabilitation; PRAISE, Pulmonary Rehabilitation Adapted Index of Self-Efficacy.